Cargando…

A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2

Patient: Male, 57-year-old Final Diagnosis: COVID-19 pneumonia • reinfection Symptoms: Cough • fever Medication: — Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Unusual clinical course BACKGROUND: Coronavirus disease 2019 (COVID-19) has radically changed the world, and promising va...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Rohit, Sardar, Sundus, Arshad, Abdullah Mohammad, Ata, Fateen, Zara, Sabeen, Munir, Waqar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718490/
https://www.ncbi.nlm.nih.gov/pubmed/33257644
http://dx.doi.org/10.12659/AJCR.927154
_version_ 1783619503743041536
author Sharma, Rohit
Sardar, Sundus
Arshad, Abdullah Mohammad
Ata, Fateen
Zara, Sabeen
Munir, Waqar
author_facet Sharma, Rohit
Sardar, Sundus
Arshad, Abdullah Mohammad
Ata, Fateen
Zara, Sabeen
Munir, Waqar
author_sort Sharma, Rohit
collection PubMed
description Patient: Male, 57-year-old Final Diagnosis: COVID-19 pneumonia • reinfection Symptoms: Cough • fever Medication: — Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Unusual clinical course BACKGROUND: Coronavirus disease 2019 (COVID-19) has radically changed the world, and promising vaccine trials are currently underway. The immune responses in asymptomatic and symptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are still under investigation, and data are evolving. While it is known that humoral and cell-mediated immune responses against SARS-CoV-2 are elicited, it is uncertain whether these responses protect against reinfection or that they provide definitive evidence of viral clearance. Very few cases have been reported in the literature regarding reinfection with SARS-CoV-2. CASE REPORT: We present a case of a middle-aged man with asymptomatic SARS-CoV-2 infection who later developed mild symptomatic COVID-19 after a period of 3 months. The source of reinfection was likely from the community, which had a soaring burden of infection with the highest number of COVID-19 cases per million in the world at that time. The patient had 2 negative COVID-19 polymerase chain reaction (PCR) tests 2 weeks after the initial infection. During the second infection, a nasopharyngeal reverse-transcription PCR test and tests for the presence of COVID-19 immunoglobulin (Ig)M and IgG antibodies were all positive. CONCLUSIONS: Reinfection with SARS-CoV-2 is a strong possibility. This case raises concerns that asymptomatic infections may not provide long-term protective immunity to all patients, which could make them susceptible to rein-fection. Possible explanations for reinfection include an interval decrease in protective antibodies titers after SARS-CoV-2 infection that may be more prevalent in patients who had an asymptomatic infection. Other possibilities include viral reactivation after a prolonged carriage of the virus or delayed immune response.
format Online
Article
Text
id pubmed-7718490
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-77184902020-12-30 A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 Sharma, Rohit Sardar, Sundus Arshad, Abdullah Mohammad Ata, Fateen Zara, Sabeen Munir, Waqar Am J Case Rep Articles Patient: Male, 57-year-old Final Diagnosis: COVID-19 pneumonia • reinfection Symptoms: Cough • fever Medication: — Clinical Procedure: — Specialty: Infectious Diseases OBJECTIVE: Unusual clinical course BACKGROUND: Coronavirus disease 2019 (COVID-19) has radically changed the world, and promising vaccine trials are currently underway. The immune responses in asymptomatic and symptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are still under investigation, and data are evolving. While it is known that humoral and cell-mediated immune responses against SARS-CoV-2 are elicited, it is uncertain whether these responses protect against reinfection or that they provide definitive evidence of viral clearance. Very few cases have been reported in the literature regarding reinfection with SARS-CoV-2. CASE REPORT: We present a case of a middle-aged man with asymptomatic SARS-CoV-2 infection who later developed mild symptomatic COVID-19 after a period of 3 months. The source of reinfection was likely from the community, which had a soaring burden of infection with the highest number of COVID-19 cases per million in the world at that time. The patient had 2 negative COVID-19 polymerase chain reaction (PCR) tests 2 weeks after the initial infection. During the second infection, a nasopharyngeal reverse-transcription PCR test and tests for the presence of COVID-19 immunoglobulin (Ig)M and IgG antibodies were all positive. CONCLUSIONS: Reinfection with SARS-CoV-2 is a strong possibility. This case raises concerns that asymptomatic infections may not provide long-term protective immunity to all patients, which could make them susceptible to rein-fection. Possible explanations for reinfection include an interval decrease in protective antibodies titers after SARS-CoV-2 infection that may be more prevalent in patients who had an asymptomatic infection. Other possibilities include viral reactivation after a prolonged carriage of the virus or delayed immune response. International Scientific Literature, Inc. 2020-12-01 /pmc/articles/PMC7718490/ /pubmed/33257644 http://dx.doi.org/10.12659/AJCR.927154 Text en © Am J Case Rep, 2020 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Sharma, Rohit
Sardar, Sundus
Arshad, Abdullah Mohammad
Ata, Fateen
Zara, Sabeen
Munir, Waqar
A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2
title A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2
title_full A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2
title_fullStr A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2
title_full_unstemmed A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2
title_short A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2
title_sort patient with asymptomatic sars-cov-2 infection who presented 86 days later with covid-19 pneumonia possibly due to reinfection with sars-cov-2
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718490/
https://www.ncbi.nlm.nih.gov/pubmed/33257644
http://dx.doi.org/10.12659/AJCR.927154
work_keys_str_mv AT sharmarohit apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT sardarsundus apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT arshadabdullahmohammad apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT atafateen apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT zarasabeen apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT munirwaqar apatientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT sharmarohit patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT sardarsundus patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT arshadabdullahmohammad patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT atafateen patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT zarasabeen patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2
AT munirwaqar patientwithasymptomaticsarscov2infectionwhopresented86dayslaterwithcovid19pneumoniapossiblyduetoreinfectionwithsarscov2